Sustained delivery formulations of risperidone compound Grant US-11712475-B2 United States of America 01 Aug 2023
Sustained release small molecule drug formulation Grant US-11110093-B2 United States of America 07 Sep 2021
Sustained delivery formulations of risperidone compound Grant US-11013809-B2 United States of America 25 May 2021
Intranasal and transdermal administration of kappa-opioid-receptor agonists: salvinorin A… Grant US-10881637-B2 United States of America 05 Jan 2021
Injectable flowable composition comprising buprenorphine Grant US-10592168-B1 United States of America 17 Mar 2020
Injectable flowable composition comprising buprenorphine Grant US-10558394-B2 United States of America 11 Feb 2020
Sustained delivery formulations of risperidone compound Grant US-10376590-B2 United States of America 13 Aug 2019
Injectable flowable composition comprising buprenorphine Grant US-10198218-B2 United States of America 05 Feb 2019
Sustained release small molecule drug formulation Grant US-10058554-B2 United States of America 28 Aug 2018
Sustained delivery formulations of risperidone compounds Grant US-10010612-B2 United States of America 03 Jul 2018